NCT01837108View on ClinicalTrials.gov

Eplerenone and Extracellular Adenosine Formation

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions

Pharmacodynamics

Interventions

DRUG

Eplerenone

2 tabs of eplerenone 25 mg will be over-encapsulated and a fully mimicking placebo will be provided by the department of clinical pharmacy of the Radboud University Medical Centre Nijmegen

DRUG

Placebo

Trial Locations (1)

6525EZ

Radboud University Medical Centre, Nijmegen

All Listed Sponsors

lead

Radboud University Medical Center

OTHER

NCT01837108 - Eplerenone and Extracellular Adenosine Formation | Biotech Hunter | Biotech Hunter